Has Nausheen Khan received payments from drug or device companies?

Yes. Drug and device makers reported $4,050 in general payments to Nausheen Khan across 224 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nausheen Khan did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nausheen Khan come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nausheen Khan

Medical · Chicago Ridge, ILNPI 1205138617

Payments from drug & device makers

$4,050in general payments, 2019–2025

Across 224 payments — averaging $18.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

GSK$1K
AstraZeneca$607
Insmed, Inc.$305
Boehringer Ingelheim$283
Electromed, Inc.$252
Inspire Medical Systems, Inc.$181
plus $1K from 16 others

What the payments were for

Food & beverage$4,039100%
Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
GSK	96	$1,346
AstraZeneca	28	$607
Insmed, Inc.	15	$305
Boehringer Ingelheim	13	$283
Electromed, Inc.	23	$252
Inspire Medical Systems, Inc.	3	$181
Merck	9	$179
Jazz Pharmaceuticals Inc.	2	$164
Sanofi	5	$135
Inogen, Inc.	7	$104
Amgen	3	$67
Takeda Pharmaceuticals U.S.A., Inc.	3	$61
Baxter Healthcare	2	$60
Teva Pharmaceuticals USA, Inc.	2	$47
ANI Pharmaceuticals, Inc.	2	$47
Genentech USA, Inc.	2	$39
Grifols USA, LLC	2	$38
Philips North America LLC	2	$36
Mylan Specialty L.p.	2	$32
Actelion Pharmaceuticals US, Inc.	1	$32
Avadel CNS Pharmaceuticals, LLC	1	$26
Paratek Pharmaceuticals, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XYWAV$150
Inspire$149
FASENRA$125

How this compares

$4,050 in reported general payments places this provider in the 85th percentile of 449 medical providers in Illinois.

See all medical providers in Illinois →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	178	$159,066
Breo ElliptaFluticasone/Vilanterol	64	$31,601
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr	45	$30,174
Breztri AerosphereBudesonide/Glycopyr/Formoterol	18	$17,422
SymbicortBudesonide/Formoterol Fumarate	38	$13,686
Albuterol Sulfate HfaAlbuterol Sulfate	167	$6,883
Stiolto RespimatTiotropium Br/Olodaterol Hcl	12	$5,613
Wixela InhubFluticasone Propion/Salmeterol	18	$4,469
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate	14	$2,829
Arnuity ElliptaFluticasone Furoate	13	$2,719
Ventolin HfaAlbuterol Sulfate	26	$2,269
Montelukast Sodium	45	$530
Azithromycin	41	$167
Prednisone	57	$151

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta	$1,346	$223,561300 claims
AstraZenecaBreztri Aerosphere, Symbicort	$607	$31,10856 claims
Boehringer IngelheimStiolto Respimat	$283	$5,61312 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 449 medical providers in Illinois.

Other medical in Chicago Ridge

Andrea TurekChicago$145K
Priya BediElmhurst$56K
Jennifer GarsonChicago$32K
Bernice JohnsonPalos Heights$32K
William KvasnickaChicago$19K
Katie SpringerLake Forest$17K
Matthew BrunoMorris$17K
Kelly BrawleyBarrington$14K
Megan GriggsSpringfield$13K
Marianne RaoAlgonquin$13K

See the full list for Illinois →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →